Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Patel Dinesh V Ph D sold 100,000 Protagonist Therapeutics, Inc. shares (Form 4)
Traded Aug 10 to Aug 11, 2026 · Filed Aug 12, 2026
From Aug 10 to Aug 11, 2026, Patel Dinesh V Ph D (Director, President and CEO) sold 100,000 Protagonist Therapeutics, Inc. shares at an average US$148.91 for US$14.9M under a trading plan, leaving 523,478 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 100,000 shares
- Price
- US$148.91 average (US$148.52 to US$149.11)
- Value
- US$14.9M
- Holding after
- 523,478 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | Common Stock | Option exercise | 65,761 | US$21.58 | 589,239 | Direct |
| Aug 10, 2026 | Common Stock | Sale | 65,761 | US$149.11 | 523,478 | Direct |
| Aug 11, 2026 | Common Stock | Option exercise | 34,239 | US$21.58 | 557,717 | Direct |
| Aug 11, 2026 | Common Stock | Sale | 34,239 | US$148.52 | 523,478 | Direct |
Source
Related
- Protagonist Therapeutics, Inc.
- Patel Dinesh V Ph D
- Protagonist Therapeutics, Inc. shareholders
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Form 4/A · Patel Dinesh V Ph D · May 14, 2026
- Form 4 · Patel Dinesh V Ph D · Apr 24, 2026
- Form 4 · Ali Asif · Oct 2, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Waddill William D. · Jun 25, 2026
- Form 4 · Waddill William D. · Jun 11, 2026